Skip to main navigation Skip to search Skip to main content

Correction: MPT0B169, a new antitubulin agent, inhibits Bcr-Abl expression and induces mitochondrion-mediated apoptosis in nonresistant and imatinib-resistant chronic myeloid leukemia cells (PLoS ONE (2016) 11:1 (e0148093) DOI: 10.1371/journal.pone.0148093)

Research output: Contribution to journalComment/debatepeer-review

Abstract

The affiliation for the third author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original languageEnglish
Article numbere0186531
JournalPLoS ONE
Volume12
Issue number10
DOIs
Publication statusPublished - Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Correction: MPT0B169, a new antitubulin agent, inhibits Bcr-Abl expression and induces mitochondrion-mediated apoptosis in nonresistant and imatinib-resistant chronic myeloid leukemia cells (PLoS ONE (2016) 11:1 (e0148093) DOI: 10.1371/journal.pone.0148093)'. Together they form a unique fingerprint.

Cite this